Selvita Services Sp. z o.o. (quality control: chemical/physical and biological parameters)
UkraineAll drugs from this manufacturer
-
The drug is used to reduce the duration and frequency of neutropenia (a decrease in neutrophil levels) in patients undergoing intensive chemotherapy. It is also prescribed for the mobilization of peripheral blood progenitor cells, for the treatment of persistent neutropenia in patients with HIV infection, and for long-term therapy in severe chronic neutropenia.
Dosage form: solution for injection or infusion
Active substance Dosage filgrastim 48 million IU (480 mcg)/0.5 mL ATC: L03AA02
-
The drug is used to reduce the duration and frequency of neutropenia (a decrease in white blood cell levels) in patients undergoing intensive chemotherapy. It is also prescribed for the mobilization of hematopoietic progenitor cells, for the treatment of severe chronic neutropenia (congenital, cyclic, or idiopathic), and to support neutrophil levels in patients with HIV infection.
Dosage form: solution for injection or infusion
Active substance Dosage filgrastim 30 million IU 300 mcg 05 mL ATC: L03AA02